Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (101)
  • 2025 (64)

Subject

  • Drug Trafficking (458)
  • Synthetic drugs (174)
  • Arrests/Convictions - Major (138)
  • Guns/Weapons (121)
  • Fentanyl Free America (87)
  • Seizures (Drugs/Property) (79)
  • Fake Pills (74)
  • Guilty Plea (68)
  • Task Forces/Task Force Officers (50)
  • Fentanyl Awareness (49)
  • Diversion Division (45)
  • Major Law Enforcement Operation (37)
  • Pharmaceuticals/Pharmacists/Physicians (30)
  • Money Laundering (29)
  • Take Back Day (22)
  • Overdose (20)
  • One Pill Can Kill (19)
  • Outreach/Drug Prevention (18)
  • Cartel (16)
  • OCDETF/Task Force (16)
  • Campaigns (14)
  • Gangs (14)
  • Other (12)
  • HIDTA (7)
  • Extraditions (6)
  • Press Conferences (6)
  • Narcoterrorism (5)
  • Prevention/Education - DEA websites GSAD, JTT etc (5)
  • Dark Web- Internet Trafficking (4)
  • Asset Forfeiture (3)
  • Critical Incident (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Terrorism (3)
  • International/Foreign Operations (2)
  • Intelligence Division - Intelligence Products (1)
  • Red Ribbon (1)
  • Counterfeit Pills (60)
  • Prescription Drugs (44)

Drug Name

  • Fentanyl (53)
  • Methamphetamine (22)
  • Cocaine (18)
  • Oxycodone (8)
  • Heroin (7)
  • Hydromorphone (3)
  • Marijuana (Cannabis) (3)
  • Ecstasy/MDMA (2)
  • Ketamine (2)
  • Benzodiazepines (1)
  • LSD (1)
  • Morphine (1)
  • Opioids (1)
  • Psilocybin (1)
  • Synthetic Opioids (1)
  • Xylazine (1)

Field Division

  • Caribbean (2)
  • Dallas (5)
  • Detroit (1)
  • El Paso (5)
  • Headquarters (5)
  • Los Angeles (1)
  • Louisville (6)
  • Miami (4)
  • New England (4)
  • New Jersey (2)
  • New Orleans (1)
  • New York (11)
  • Omaha (12)
  • Phoenix (1)
  • Rocky Mountain (5)
  • San Diego (1)
  • San Francisco (7)
  • Seattle (22)
  • St. Louis (6)
Clear All Results
View Archived Press Releases
101 Results - Showing 1 to 10
PRESS RELEASE

Orlando Pharmacy and Pharmacist Agree to Pay $50,000 to Settle Controlled Substances Act Violations

Orlando, FL – Plaza Pharmacy, LLC and Paul Ezeobinwa have agreed to pay the United States $50,000 to resolve allegations that they violated the Controlled Substances Act by improperly distributing schedule V drugs and committing multiple recordkeeping violations. U.S. Attorney Gregory W. Kehoe made the announcement. “Our Diversion investigators will...
PRESS RELEASE

Two Seattle Area Men Charged with String of Pharmacy Burglaries Throughout the Puget Sound Region

SEATTLE – Two men have been charged in a 24-count indictment following the investigation of a string of pharmacy burglaries that stretched from Kirkland, Washington, to Chehalis, Washington. Koumssa Wakgira, 44, of Seattle and Juston Young, 42, of Renton, Washington, are charged in an indictment alleging conspiracy to commit burglaries...
PRESS RELEASE

Health Care Fraud Unit Secures Result in Landmark Case Targeting Executives of Fraudulent Mental Health Technology Company That Distributed over 37 Million Pills of Adderall

San Francisco – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA San Francisco Division Special Agent in Charge Bob Beris, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

St. Louis Area Man Sentenced to 200 Months in Prison for Conspiracy that Led to Overdose of Two Teens

ST. LOUIS – U.S. District Judge Cristian M. Stevens on Tuesday sentenced a man who was involved in a drug conspiracy that caused one fatal and one nonfatal overdose to 200 months in prison. Haeder Jameel, 23, was also ordered to pay $51,005 in restitution to the parents of the...
PRESS RELEASE

Digital Health Company Founder/CEO & Clinical President Sentenced in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, DEA San Francisco Division Special Agent in Charge Bob Beris, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Founder/CEO and Clinical President of Digital Health Company Sentenced for $90 Million Scheme to Distribute over 37 Million Pills of Adderall

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...
PRESS RELEASE

Former Albuquerque Dentist Ordered to Pay $320,000 for Violating Controlled Substances and False Claims Acts

ALBUQUERQUE – The DEA and the U.S. Attorney's Office announced today that a federal court has entered a $320,000.00 judgment against a former Albuquerque dentist to resolve allegations that he violated the Controlled Substances Act (CSA) by unlawfully issuing prescriptions after his professional licenses were revoked or expired. William C...
PRESS RELEASE

DEA Rocky Mountain Field Division Issues Warning After SW Lab Findings

CENTENNIAL, CO – The Drug Enforcement Administration's Rocky Mountain Field Division (RMFD) is issuing a warning after DEA's Southwest Laboratory identified illicit pills containing mixtures of both deadly fentanyl/carfentanil and fentanyl/heroin. The drugs were found in tablets after lab analyses of recent seizures in both Colorado and Utah. "With these...
PRESS RELEASE

Mexican National Unlawfully Residing in the United States Charged with Drug and Firearm Offenses in Oregon

PORTLAND, Ore.—A Mexican national unlawfully residing in the United States has been indicted after investigators seized over 17.5 pounds of narcotics, firearms, and cash. Baltazar Plata Bringas, 31, has been charged with conspiracy to distribute and possess with intent to distribute methamphetamine and fentanyl, possession with intent to distribute methamphetamine...
PRESS RELEASE

Upstate New York Operation Leads to 83 Arrests and Numerous Drug Seizures

SARATOGA, NEW YORK – Operation Fast Track has led to the arrest of 83 defendants and the seizure of more than 2,100 counterfeit pills, some of which are suspected to be laced with fentanyl, over two kilograms of fentanyl and heroin, over a kilogram of cocaine, 3.5 pounds of psychedelic...

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster